• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Seattle Genetics Inc. (SGEN)

    -NasdaqGS
    31.10 Down 0.14(0.45%) Dec 24, 12:59PM EST
    Add to Portfolio
    Prev Close:31.24
    Open:30.83
    Bid:16.65 x 100
    Ask:N/A
    1y Target Est:46.23
    Beta:2.26
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:30.80 - 32.05
    52wk Range:30.50 - 55.99
    Volume:787,480
    Avg Vol (3m):1,381,620
    Market Cap:3.85B
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 0.45%3.85B
    IMGNUp 2.25%507.02M
    PFEDown 0.10%197.97B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.66
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-4.67

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback